肉水性提取物的抗癌作用:关注血液恶性瘤
Santino Caserta1, Claudia Genovese2, Nicola Cicero3
1Division of Hematology, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University of Messina, Via Consolare Valeria, 98125 Messina, Italy.
Life (Basel, Switzerland)
|May 27, 2023
概括
水性肉提取物显示出作为抗癌剂的潜力,特别是在血液性恶性瘤中. 需要进一步的研究来证实其在癌症治疗中的疗效和临床应用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 自然产品化学 自然产品化学
背景情况:
- 肉 (Lauraceae家族) 是一种热带植物,其水性提取物被研究为抗癌性质.
- 临床前研究表明,肉提取物会影响参与癌症扩散和生存的细胞通路.
研究的目的:
- 审查体外和体外关于水性肉提取物在血液恶性瘤中的抗癌作用的研究.
- 探索 cinnamon 提取物抗癌作用背后的分子机制.
- 讨论肉提取物在癌症治疗中的潜在临床应用.
主要方法:
- 对水性肉提取物的现有体外和体内研究进行审查.
- 对肉提取物准的细胞通路的分析,包括NF-KB,AP-1,COX-2,二叶酸减少酶,VEGF和CD8+ T细胞.
- 评估单独使用肉提取物和与化疗 (如多克索鲁比辛) 结合使用的疗效.
主要成果:
- 实验室和体内研究表明,水性肉提取物可以降低对促增殖和促生存分子的调节.
- 提取物似乎对免疫细胞对抗瘤的活性进行上调,例如细胞毒性CD8+ T细胞.
- 肉提取物在治疗血液性恶性瘤方面显示出潜在的潜力,无论是作为独立治疗还是辅助治疗.
结论:
- 水性肉提取物通过调节关键细胞通路,显示出有前途的抗癌活性,对抗血液性恶性瘤.
- 虽然临床前数据令人鼓舞,但进一步的临床研究至关重要,以确定肉提取物在癌症患者中的安全性,疗效和最佳使用.
- 肉提取物作为补充或替代癌症治疗的潜力需要继续研究.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


